Max Jaderberg

Max Jaderberg is a prominent researcher and executive in the field of artificial intelligence, currently serving as the Chief AI Officer at isomorphic-labs. He is a key figure in the application of deep learning to scientific discovery, particularly in drug design.

Professional History

• Former researcher at Google DeepMind, contributing to foundational work in reinforcement learning and AI.
• Key member of the team behind AlphaFold, the AI system that revolutionized protein structure prediction.
• Joined Isomorphic Labs (a Google DeepMind spin-off) to lead AI-driven drug discovery efforts.

Current Role at Isomorphic Labs

• Title: Chief AI Officer.
• Focus: Leveraging AI to accelerate and transform the process of drug discovery and design.
• Key Contributions:
  • Integrating advanced AI models into medicinal drug design workflows.
  • Bridging the gap between computational biology and pharmaceutical development.
  • Advocating for the use of AI to solve complex biological problems, such as protein folding and molecular interaction.

Media & Publications

• Featured in the Google DeepMind podcast episode: Isomorphic Labs: AlphaFold’s AI Revolutionizing Drug Discovery and Design.
  • Discussed the role of AI in curing diseases and the future of medicinal drug design.
  • Isomorphic Labs: AlphaFold’s AI Revolutionizing Drug Discovery and Design(https://www.youtube.com/watch?v=XpIMuCeEtSk)

Related Entities

• isomorphic-labs
• google-deepmind
• AlphaFold
• rebecca-paul